James L. Zehnder

17.1k total citations · 1 hit paper
231 papers, 8.4k citations indexed

About

James L. Zehnder is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, James L. Zehnder has authored 231 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Hematology, 63 papers in Genetics and 48 papers in Molecular Biology. Recurrent topics in James L. Zehnder's work include Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Acute Myeloid Leukemia Research (26 papers). James L. Zehnder is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Acute Myeloid Leukemia Research (26 papers). James L. Zehnder collaborates with scholars based in United States, Canada and China. James L. Zehnder's co-authors include Carol D. Jones, Jason Gotlib, LL Leung, Catriona Jamieson, Irving L. Weissman, Roger A. Warnke, Ruchira Sood, Armand Keating, Jason D. Merker and Maurice L. Druzin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James L. Zehnder

224 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML

2004 1.1k citations Carol D. Jones, James L. Zehnder et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James L. Zehnder United States	47	3.2k	2.2k	1.8k	1.6k	1.4k	231	8.4k
Giorgio La Nasa Italy	45	2.3k 0.7×	1.8k 0.8×	2.7k 1.5×	1.3k 0.8×	866 0.6×	275	6.7k
Alberto Bosi Italy	57	6.1k 1.9×	2.3k 1.1×	3.6k 2.0×	2.3k 1.4×	1.5k 1.1×	321	10.5k
Rajesh Chopra United Kingdom	48	3.2k 1.0×	2.6k 1.2×	1.6k 0.8×	2.8k 1.8×	2.3k 1.6×	171	8.9k
Mauricette Michallet France	50	6.9k 2.2×	2.0k 0.9×	2.2k 1.2×	2.6k 1.6×	996 0.7×	311	10.0k
Mine Harada Japan	49	2.7k 0.9×	2.4k 1.1×	1.0k 0.6×	2.7k 1.7×	850 0.6×	375	10.2k
Philip L. McCarthy United States	49	4.8k 1.5×	1.7k 0.8×	1.5k 0.8×	2.4k 1.5×	1.1k 0.8×	309	8.5k
Augustin Ferrant Belgium	52	6.5k 2.1×	2.5k 1.1×	2.3k 1.3×	3.1k 1.9×	1.7k 1.2×	225	10.9k
Shinichiro Okamoto Japan	41	3.3k 1.0×	1.1k 0.5×	1.3k 0.7×	1.5k 0.9×	467 0.3×	389	7.1k
Mrinal M. Patnaik United States	51	5.5k 1.7×	2.7k 1.2×	4.0k 2.2×	875 0.5×	714 0.5×	479	9.0k
Axel R. Zander Germany	49	3.8k 1.2×	2.0k 0.9×	2.2k 1.2×	1.7k 1.1×	311 0.2×	228	7.3k

Countries citing papers authored by James L. Zehnder

Since Specialization

Citations

This map shows the geographic impact of James L. Zehnder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Zehnder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Zehnder more than expected).

Fields of papers citing papers by James L. Zehnder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Zehnder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Zehnder. The network helps show where James L. Zehnder may publish in the future.

Co-authorship network of co-authors of James L. Zehnder

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Zehnder. A scholar is included among the top collaborators of James L. Zehnder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Zehnder. James L. Zehnder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Jing, Santosh Gummidipundi, Joe L. Hsu, et al.. (2024). Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality. Seminars in Thrombosis and Hemostasis. 51(6). 667–675.

Liu, Yi, Jason Wu, Kanagavel Murugesan, et al.. (2023). Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens. Blood Advances. 7(18). 5433–5445. 3 indexed citations

Tung, Jack K., Michael S. Khodadoust, Youn H. Kim, et al.. (2023). Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor. Journal of Molecular Diagnostics. 25(6). 331–341.

Zehnder, James L., James B. Bussel, & Nichola Cooper. (2023). The role of genetics in refractory immune thrombocytopenia. British Journal of Haematology. 203(1). 62–64. 1 indexed citations

Luo, Ruben Yiqi, et al.. (2023). Study of β1-transferrin and β2-transferrin using microprobe-capture in-emitter elution and high-resolution mass spectrometry. Scientific Reports. 13(1). 14974–14974. 4 indexed citations

Kumar, Jyoti, Samit Patel, Soham Mukherjee, et al.. (2023). Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior nonhematopoietic malignancies, cytogenetic abnormalities, and WHO category. Human Pathology. 135. 45–53. 2 indexed citations

Wirz, Oliver F., Katharina Röltgen, Bryan Stevens, et al.. (2021). Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion. Frontiers in Immunology. 12. 739037–739037. 3 indexed citations

Stevens, Bryan, Malaya K. Sahoo, ChunHong Huang, et al.. (2021). Plasma as an alternative COVID-19 diagnostic specimen in a hospitalized patient negative for SARS-CoV-2 by nasopharyngeal swab. Diagnostic Microbiology and Infectious Disease. 100(3). 115365–115365. 1 indexed citations

Devereaux, Kelly A., David F. Steiner, Adam J. Gomez, et al.. (2021). A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma. International Journal of Gynecological Pathology. 41(6). 541–551. 18 indexed citations

10.

Stevens, Bryan, Catherine A. Hogan, Kenji O. Mfuh, et al.. (2021). Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system. Journal of Clinical Virology. 138. 104792–104792. 2 indexed citations

11.

Shomali, William, Alisa Damnernsawad, David A. Sampson, et al.. (2021). A novel activating JAK1 mutation in chronic eosinophilic leukemia. Blood Advances. 5(18). 3581–3586. 10 indexed citations

12.

Hogan, Catherine A., Natasha Garamani, Andrew S. Lee, et al.. (2020). Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens. Journal of Clinical Microbiology. 58(8). 53 indexed citations

13.

Hogan, Catherine A., Bryan Stevens, Malaya K. Sahoo, et al.. (2020). High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clinical Infectious Diseases. 72(9). e291–e295. 67 indexed citations

14.

Fernandez‐Pol, Sebastian, Erica Wang, Kerri E. Rieger, et al.. (2020). Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports. Diagnostic Pathology. 15(1). 122–122. 10 indexed citations

15.

Yang, Soo‐Ryum, Kelly L. Mooney, Carol D. Jones, et al.. (2019). Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology. Cancer Cytopathology. 128(1). 43–56. 22 indexed citations

16.

Forgó, Erna, Adam J. Gomez, David F. Steiner, James L. Zehnder, & Teri A. Longacre. (2019). Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE). Histopathology. 76(3). 366–374. 16 indexed citations

17.

Jager, Astraea, Pablo Domizi, Mara Pavel-Dinu, et al.. (2019). High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells. Blood Advances. 3(19). 2825–2835. 25 indexed citations

18.

Hinds, David A., Kimberly E. Barnholt, Ruben A. Mesa, et al.. (2016). Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood. 128(8). 1121–1128. 171 indexed citations

19.

Carlson, Joseph J., John W. Farquhar, James L. Zehnder, et al.. (2007). Safety and Efficacy of a Ginkgo Biloba–Containing Dietary Supplement on Cognitive Function, Quality of Life, and Platelet Function in Healthy, Cognitively Intact Older Adults. Journal of the American Dietetic Association. 107(3). 422–432. 27 indexed citations

20.

Schrijver, Iris, Marla Lay, & James L. Zehnder. (2004). Rapid Combined Genotyping Assay for Four Achondroplasia and Hypochondroplasia Mutations by Real-Time PCR with Multiple Detection Probes. Genetic Testing. 8(2). 185–189. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact